How does CAJ's PS Ratio compare to its peers?

CAJ is expensive based on its Price-To-Sales Ratio (1.7x) compared to the peer average (1.2x).

How does CAJ's PS Ratio compare vs other companies in the AU Healthcare Industry?

CAJ is expensive based on its Price-To-Sales Ratio (1.7x) compared to the Oceanic Healthcare industry average (1.4x).

What is CAJ's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

CAJ is expensive based on its Price-To-Sales Ratio (1.7x) compared to the estimated Fair Price-To-Sales Ratio (0.8x).

What is the Fair Price of CAJ when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

CAJ (A$0.38) is trading above our estimate of [[fair value]] (A$0.33)

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Target price is lower than the current share price.

Capitol Health (ASX:CAJ) - Stock Price, News & Analysis

CAJ Stock Overview

Provides diagnostic imaging modalities and related services to the healthcare market in Australia. More details

CAJ fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	4/6
Past Performance	0/6
Financial Health	2/6
Dividends	1/6

Rewards

Earnings are forecast to grow 68.36% per year

Risk Analysis

Has a high level of debt

Capitol Health Limited Competitors

Integral Diagnostics

ASX:IDX

AU$666.7m

Australian Clinical Labs

ASX:ACL

AU$689.5m

Healthia

ASX:HLA

AU$252.1m

SILK Laser Australia

ASX:SLA

AU$177.4m

Price History & Performance

Summary of all time highs, changes and price drops for Capitol Health
Historical stock prices
Current Share Price	AU$0.38
52 Week High	AU$0.39
52 Week Low	AU$0.20
Beta	0.65
11 Month Change	4.17%
3 Month Change	17.19%
1 Year Change	74.42%
33 Year Change	7.14%
5 Year Change	63.04%
Change since IPO	41.51%

Recent updates

Capitol Health Limited's (ASX:CAJ) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Mar 05

Have Insiders Been Selling Capitol Health Limited (ASX:CAJ) Shares This Year?

Feb 14

Did You Miss Capitol Health's (ASX:CAJ) 20% Share Price Gain?

Jan 19

Is Capitol Health Limited's (ASX:CAJ) Shareholder Ownership Skewed Towards Insiders?

Dec 22

Capitol Health Limited's (ASX:CAJ) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Dec 01

Here's Why We Don't Think Capitol Health's (ASX:CAJ) Statutory Earnings Reflect Its Underlying Earnings Potential

Aug 17

Is Now An Opportune Moment To Examine Capitol Health Limited (ASX:CAJ)?

Jul 25

Is Capitol Health Limited's (ASX:CAJ) Latest Stock Performance A Reflection Of Its Financial Health?

Jul 04

Shareholder Returns

	CAJ	AU Healthcare	AU Market
7D	2.7%	4.0%	0.5%
1Y	74.4%	10.3%	17.4%

Return vs Industry: CAJ exceeded the Australian Healthcare industry which returned 10.3% over the past year.

Return vs Market: CAJ exceeded the Australian Market which returned 17.4% over the past year.

Price Volatility

Is CAJ's price volatile compared to industry and market?
CAJ volatility
CAJ Average Weekly Movement	4.8%
Healthcare Industry Average Movement	4.8%
Market Average Movement	8.3%
10% most volatile stocks in AU Market	17.0%
10% least volatile stocks in AU Market	3.2%

Stable Share Price: CAJ has not had significant price volatility in the past 3 months compared to the Australian market.

Volatility Over Time: CAJ's weekly volatility (5%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
2005	1,000	Justin Walter	www.capitolhealth.com.au

Capitol Health Limited provides diagnostic imaging modalities and related services to the healthcare market in Australia. It offers a range of diagnostic imaging services, including general x-ray, magnetic resonance imaging, ultrasound, mammography, Doppler, orthopantomogram, echocardiography, computed tomography, CT angiography, cone beam CT, nuclear medicine, bone densitometry, and fluoroscopy. It operates various clinics in Victoria, Tasmania, Western Australia, and South Australia under the Capital Radiology brand, as well as under the Imaging Olympic Park, Radiology Tasmania, Fowler Simmons Radiology, Womens’ Imaging, Direct Radiology, and Future Medical Imaging Group brand names.

Capitol Health Limited Fundamentals Summary

How do Capitol Health's earnings and revenue compare to its market cap?
CAJ fundamental statistics
Market cap	AU$378.46m
Earnings (TTM)	-AU$14.85m
Revenue (TTM)	AU$234.82m

1.7x

P/S Ratio

-26.9x

P/E Ratio

Is CAJ overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CAJ income statement (TTM)
Revenue	AU$234.82m
Cost of Revenue	AU$178.96m
Gross Profit	AU$55.86m
Other Expenses	AU$70.71m
Earnings	-AU$14.85m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	-0.014
Gross Margin	23.79%
Net Profit Margin	-6.33%
Debt/Equity Ratio	74.8%

How did CAJ perform over the long term?

See historical performance and comparison

Dividends

2.1%

Current Dividend Yield

-64%

Payout Ratio

CAJ Stock Overview

Rewards

Risk Analysis

Capitol Health Limited Competitors

ASX:IDX

AU$666.7m

ASX:ACL

AU$689.5m

ASX:HLA

AU$252.1m

ASX:SLA

AU$177.4m

Price History & Performance

Recent News & Updates

Insufficient new directors

Capitol Health Limited, Annual General Meeting, Feb 28, 2025

Final dividend of AU$0.004 announced

Price target increased by 7.1% to AU$0.31

Full year 2024 earnings released: AU$0.014 loss per share (vs AU$0.011 loss in FY 2023)

Capitol Health Limited Provides Earnings Guidance for the Year 2025

Recent updates

Insufficient new directors

Capitol Health Limited, Annual General Meeting, Feb 28, 2025

Final dividend of AU$0.004 announced

Price target increased by 7.1% to AU$0.31

Full year 2024 earnings released: AU$0.014 loss per share (vs AU$0.011 loss in FY 2023)

Capitol Health Limited Provides Earnings Guidance for the Year 2025

Capitol Health Limited to Report Fiscal Year 2024 Results on Aug 22, 2024

Integral Diagnostics Limited (ASX:IDX) agreed to acquire Capitol Health Limited (ASX:CAJ) for approximately AUD 350 million.

Integral Diagnostics Limited (ASX:IDX) agreed to acquire Capitol Health Limited (ASX:CAJ) for approximately AUD 350 million.

Calculating The Fair Value Of Capitol Health Limited (ASX:CAJ)

Now 21% undervalued after recent price drop

Now 21% undervalued

First half dividend of AU$0.005 announced

First half 2024 earnings released: EPS: AU$0.002 (vs AU$0.015 loss in 1H 2023)

New major risk - Financial position

Now 20% undervalued

Capitol Health Limited to Report First Half, 2024 Results on Feb 29, 2024

Capitol Health Limited Appoints Brendon Pentland as the Chief Financial Officer, Effective 1 April 2024

Capitol Health Limited's (ASX:CAJ) Popularity With Investors Is Clear

Capitol Health (ASX:CAJ) Takes On Some Risk With Its Use Of Debt

Now 21% undervalued

Now 21% undervalued after recent price drop

Capitol Health Limited Announces the Resignation of Craig Bremner as Chief Financial Officer

Now 20% undervalued after recent price drop

Now 20% undervalued after recent price drop

Price target decreased by 9.8% to AU$0.28

Capitol Health Limited, Annual General Meeting, Nov 15, 2023

Full year 2023 earnings: EPS misses analyst expectations

Capitol Health Limited to Report Fiscal Year 2023 Results on Aug 24, 2023

Price target decreased by 9.6% to AU$0.33

Capitol Health Limited to Report First Half, 2023 Results on Feb 23, 2023

Now 21% undervalued

Now 21% undervalued

Capitol Health Limited (ASX:CAJ) completed the acquisition of Future Medical Imaging Group Pty Ltd.

Is Capitol Health Limited (ASX:CAJ) Worth AU$0.3 Based On Its Intrinsic Value?

Capitol Health Limited Declares Franked Dividend for the Six Months Ended June 30, 2022, Payable on October 21, 2022

Price target increased to AU$0.43

Capitol Health Limited, Annual General Meeting, Nov 15, 2022

Full year 2022 earnings: EPS misses analyst expectations

Capitol Health Limited Announces Dividend for the Six Months Ended June 30, 2022, Payable on 21 October, 2022

Consensus EPS estimates fall by 12%

First half 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Capitol Health Limited Announces Dividend for the Six Months Ended December 31, 2021, Payable on April 1, 2022

Capitol Health Limited to Report First Half, 2022 Results on Feb 24, 2022

Full year 2021 earnings released: EPS AU$0.012 (vs AU$0.001 in FY 2020)

Capitol Health (ASX:CAJ) Seems To Use Debt Rather Sparingly

Should You Investigate Capitol Health Limited (ASX:CAJ) At AU$0.37?

Capitol Health Limited's (ASX:CAJ) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Analysts increase EPS estimates to AU$0.012

First half 2021 earnings released: EPS AU$0.006 (vs AU$0.004 in 1H 2020)

Price target raised to AU$0.36

New 90-day high: AU$0.34

Have Insiders Been Selling Capitol Health Limited (ASX:CAJ) Shares This Year?

Capitol Health Limited (ASX:CAJ) acquired Direct Radiology.

Capitol Health Limited to Report First Half, 2021 Results on Feb 24, 2021

New 90-day high: AU$0.28

Did You Miss Capitol Health's (ASX:CAJ) 20% Share Price Gain?

Is Capitol Health Limited's (ASX:CAJ) Shareholder Ownership Skewed Towards Insiders?

Capitol Health Limited's (ASX:CAJ) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?